NK Cell Precursors in Human Bone Marrow in Health and Inflammation

Area of Science:

• Immunology
• Hematopoiesis
• Cell Biology

Background:

• Natural Killer (NK) cells develop from hematopoietic stem cells (HSCs) in the bone marrow (BM).
• NK cell development primarily occurs outside the BM, involving progenitor cells migrating to secondary lymphoid organs.
• Multipotent CD34+ common lymphoid progenitors (CLPs) in the BM generate various immune cells but lack myeloid potential.

Purpose of the Study:

• To investigate the role of inflammation in regulating HSC maturation and progenitor release from the BM.
• To identify and characterize novel progenitor populations involved in lymphopoiesis during disease states.
• To challenge the assumption that lymphopoiesis in disease mirrors healthy models.

Main Methods:

• Analysis of progenitor cell populations in bone marrow during systemic inflammation.
• Characterization of cell surface markers (Lin-, CD34+, DNAM-1, CXCR4) to identify specific progenitor subsets.
• Investigating the developmental trajectory and functional potential of identified progenitor cells.

Main Results:

• A previously overlooked CLP subset (Lin-CD34+DNAM-1brightCXCR4+) was identified in the BM.
• This "inflammatory" CLP subset significantly exits the BM during systemic inflammation.
• These precursors differentiate into functional NK and T cells, distinct from steady-state precursors (CD34+DNAM-1-CXCR4-).

Conclusions:

• Systemic inflammation induces the release of a specific CLP subset from the BM.
• This subset contributes to NK and T cell generation, highlighting a distinct inflammatory lymphopoiesis pathway.
• Incorporating "inflammatory" progenitor models is crucial for understanding NK cell precursor development and therapeutic interventions.